Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Protection from Cardiac Arrhythmia Through Ryanodine Receptor-Stabilizing Protein Calstabin2
Xander H. T. Wehrens,1,2*
Stephan E. Lehnart,1,2*
Steven R. Reiken,1,2
Shi-Xian Deng,3
John A. Vest,1,2,3
Daniel Cervantes,3
James Coromilas,3
Donald W. Landry,3
Andrew R. Marks1,2,3
Abstract:
Ventricular arrhythmias can cause sudden cardiac death (SCD)in patients with normal hearts and in those with underlyingdisease such as heart failure. In animals with heart failureand in patients with inherited forms of exercise-induced SCD,depletion of the channel-stabilizing protein calstabin2 (FKBP12.6)from the ryanodine receptorcalcium release channel (RyR2)complex causes an intracellular Ca2+ leak that can trigger fatalcardiac arrhythmias. A derivative of 1,4-benzothiazepine (JTV519)increased the affinity of calstabin2 for RyR2, which stabilizedthe closed state of RyR2 and prevented the Ca2+ leak that triggersarrhythmias. Thus, enhancing the binding of calstabin2 to RyR2may be a therapeutic strategy for common ventricular arrhythmias.
1 Department of Physiology and Cellular Biophysics, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA. 2 Center for Molecular Cardiology, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA. 3 Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA.
Bradycardia alters Ca2+ dynamics enhancing dispersion of repolarization and arrhythmia risk.
J. J. Kim, J. Nemec, R. Papp, R. Strongin, J. J. Abramson, and G. Salama (2013)
Am J Physiol Heart Circ Physiol
304, H848-H860
|Abstract »|Full Text »|PDF »
Protective Effect of K201 on Isoproterenol-Induced and Ischemic-Reperfusion-Induced Ventricular Arrhythmias in the Rat: Comparison With Diltiazem.
N. Otani, R. Matsuda, K. Oda, S. Nishino, T. Inoue, and N. Kaneko (2013)
Journal of Cardiovascular Pharmacology and Therapeutics
18, 184-190
|Abstract »|Full Text »|PDF »
A network-oriented perspective on cardiac calcium signaling.
C. H. George, D. Parthimos, and N. C. Silvester (2012)
Am J Physiol Cell Physiol
303, C897-C910
|Abstract »|Full Text »|PDF »
Ryanodine Receptor Phosphorylation and Heart Failure: Phasing Out S2808 and "Criminalizing" S2814.
H. H. Valdivia (2012)
Circ. Res.
110, 1398-1402
|Full Text »|PDF »
Acute Coronary Events.
A. Arbab-Zadeh, M. Nakano, R. Virmani, and V. Fuster (2012)
Circulation
125, 1147-1156
|Full Text »|PDF »
Therapeutic approach for patients with catecholaminergic polymorphic ventricular tachycardia: state of the art and future developments.
C. van der Werf, A. H. Zwinderman, and A. A. M. Wilde (2012)
Europace
14, 175-183
|Abstract »|Full Text »|PDF »
Designing Calcium Release Channel Inhibitors with Enhanced Electron Donor Properties: Stabilizing the Closed State of Ryanodine Receptor Type 1.
Y. Ye, D. Yaeger, L. J. Owen, J. O. Escobedo, J. Wang, J. D. Singer, R. M. Strongin, and J. J. Abramson (2012)
Mol. Pharmacol.
81, 53-62
|Abstract »|Full Text »|PDF »
Inherited Dysfunction of Sarcoplasmic Reticulum Ca2+ Handling and Arrhythmogenesis.
The ryanodine receptor channel as a molecular motif in atrial fibrillation: pathophysiological and therapeutic implications.
D. Dobrev, N. Voigt, and X. H. T. Wehrens (2011)
Cardiovasc Res
89, 734-743
|Abstract »|Full Text »|PDF »
Acute atrial arrhythmogenicity and altered Ca2+ homeostasis in murine RyR2-P2328S hearts.
Y. Zhang, J. A. Fraser, K. Jeevaratnam, X. Hao, S. S. Hothi, A. A. Grace, M. Lei, and C. L.- H. Huang (2011)
Cardiovasc Res
89, 794-804
|Abstract »|Full Text »|PDF »
Ryanodine Receptor Phosphorylation by Calcium/Calmodulin-Dependent Protein Kinase II Promotes Life-Threatening Ventricular Arrhythmias in Mice With Heart Failure.
R. J. van Oort, M. D. McCauley, S. S. Dixit, L. Pereira, Y. Yang, J. L. Respress, Q. Wang, A. C. De Almeida, D. G. Skapura, M. E. Anderson, et al. (2010)
Circulation
122, 2669-2679
|Abstract »|Full Text »|PDF »
Perspectives on: Local calcium signaling: Subcellular Ca2+ signaling in the heart: the role of ryanodine receptor sensitivity.
B. L. Prosser, C. W. Ward, and W. J. Lederer (2010)
J. Gen. Physiol.
136, 135-142
|Full Text »|PDF »
Ca2+ Cycling and New Therapeutic Approaches for Heart Failure.
A.-M. Lompre, R. J. Hajjar, S. E. Harding, E. G. Kranias, M. J. Lohse, and A. R. Marks (2010)
Circulation
121, 822-830
|Full Text »|PDF »
Leaky RyR2 trigger ventricular arrhythmias in Duchenne muscular dystrophy.
J. Fauconnier, J. Thireau, S. Reiken, C. Cassan, S. Richard, S. Matecki, A. R. Marks, and A. Lacampagne (2010)
PNAS
107, 1559-1564
|Abstract »|Full Text »|PDF »
Sudden Infant Death Syndrome in Mice With an Inherited Mutation in RyR2.
N. Mathur, S. Sood, S. Wang, R. J. van Oort, S. Sarma, N. Li, D. G. Skapura, J. H. Bayle, M. Valderrabano, and X. H.T. Wehrens (2009)
Circ Arrhythm Electrophysiol
2, 677-685
|Abstract »|Full Text »|PDF »
Role of coupled gating between cardiac ryanodine receptors in the genesis of triggered arrhythmias.
W. Chen, J. A. Wasserstrom, and Y. Shiferaw (2009)
Am J Physiol Heart Circ Physiol
297, H171-H180
|Abstract »|Full Text »|PDF »
Mineralocorticoid Modulation of Cardiac Ryanodine Receptor Activity Is Associated With Downregulation of FK506-Binding Proteins.
A. M. Gomez, A. Rueda, Y. Sainte-Marie, L. Pereira, S. Zissimopoulos, X. Zhu, R. Schaub, E. Perrier, R. Perrier, C. Latouche, et al. (2009)
Circulation
119, 2179-2187
|Abstract »|Full Text »|PDF »
Estrogen Inhibits Cardiac Hypertrophy: Role of Estrogen Receptor-{beta} to Inhibit Calcineurin.
A. Pedram, M. Razandi, D. Lubahn, J. Liu, M. Vannan, and E. R. Levin (2008)
Endocrinology
149, 3361-3369
|Abstract »|Full Text »|PDF »
Conditional FKBP12.6 Overexpression in Mouse Cardiac Myocytes Prevents Triggered Ventricular Tachycardia Through Specific Alterations in Excitation- Contraction Coupling.
B. Gellen, M. Fernandez-Velasco, F. Briec, L. Vinet, K. LeQuang, P. Rouet-Benzineb, J.-P. Benitah, M. Pezet, G. Palais, N. Pellegrin, et al. (2008)
Circulation
117, 1778-1786
|Abstract »|Full Text »|PDF »
Remodeling of ryanodine receptor complex causes "leaky" channels: A molecular mechanism for decreased exercise capacity.
A. M. Bellinger, S. Reiken, M. Dura, P. W. Murphy, S.-X. Deng, D. W. Landry, D. Nieman, S. E. Lehnart, M. Samaru, A. LaCampagne, et al. (2008)
PNAS
105, 2198-2202
|Abstract »|Full Text »|PDF »
Identification of Target Domains of the Cardiac Ryanodine Receptor to Correct Channel Disorder in Failing Hearts.
T. Yamamoto, M. Yano, X. Xu, H. Uchinoumi, H. Tateishi, M. Mochizuki, T. Oda, S. Kobayashi, N. Ikemoto, and M. Matsuzaki (2008)
Circulation
117, 762-772
|Abstract »|Full Text »|PDF »
Toward Biologically Targeted Therapy of Calcium Cycling Defects in Heart Failure.
Removal of FKBP12.6 Does Not Alter the Conductance and Activation of the Cardiac Ryanodine Receptor or the Susceptibility to Stress-induced Ventricular Arrhythmias.
J. Xiao, X. Tian, P. P. Jones, J. Bolstad, H. Kong, R. Wang, L. Zhang, H. J. Duff, A. M. Gillis, S. Fleischer, et al. (2007)
J. Biol. Chem.
282, 34828-34838
|Abstract »|Full Text »|PDF »
Inherited Arrhythmias: A National Heart, Lung, and Blood Institute and Office of Rare Diseases Workshop Consensus Report About the Diagnosis, Phenotyping, Molecular Mechanisms, and Therapeutic Approaches for Primary Cardiomyopathies of Gene Mutations Affecting Ion Channel Function.
S. E. Lehnart, M. J. Ackerman, D. W. Benson Jr, R. Brugada, C. E. Clancy, J. K. Donahue, A. L. George Jr, A. O. Grant, S. C. Groft, C. T. January, et al. (2007)
Circulation
116, 2325-2345
|Abstract »|Full Text »|PDF »
RyR1-specific requirement for depolarization-induced Ca2+ sparks in urinary bladder smooth muscle.
N. Fritz, J.-L. Morel, L. H. Jeyakumar, S. Fleischer, P. D. Allen, J. Mironneau, and N. Macrez (2007)
J. Cell Sci.
120, 3784-3791
|Abstract »|Full Text »|PDF »
Inhibition of SR Ca2+ uptake: A novel action of the RyR2-FKBP12.6 antagonist K201.
A. F. James (2007)
Cardiovasc Res
76, 199-201
|Full Text »|PDF »
Expanding Spectrum of Human RYR2-Related Disease: New Electrocardiographic, Structural, and Genetic Features.
Z. A. Bhuiyan, M. P. van den Berg, J. P. van Tintelen, M. T.E. Bink-Boelkens, A. C.P. Wiesfeld, M. Alders, A. V. Postma, I. van Langen, M. M.A.M. Mannens, and A. A.M. Wilde (2007)
Circulation
116, 1569-1576
|Abstract »|Full Text »|PDF »
Mechanisms of Human Arrhythmia Syndromes: Abnormal Cardiac Macromolecular Interactions.
Phosphorylation of the Cardiac Ryanodine Receptor by Ca2+/Calmodulin-Dependent Protein Kinase II: The Dominating Twin of Protein Kinase A?.
J. Kockskamper and B. Pieske (2006)
Circ. Res.
99, 333-335
|Full Text »|PDF »
Life, Sudden Death, and Intracellular Calcium.
D.A. Eisner, L.A. Venetucci, and A.W. Trafford (2006)
Circ. Res.
99, 223-224
|Full Text »|PDF »
Arrhythmogenesis in Catecholaminergic Polymorphic Ventricular Tachycardia: Insights From a RyR2 R4496C Knock-In Mouse Model.
N. Liu, B. Colombi, M. Memmi, S. Zissimopoulos, N. Rizzi, S. Negri, M. Imbriani, C. Napolitano, F. A. Lai, and S. G. Priori (2006)
Circ. Res.
99, 292-298
|Abstract »|Full Text »|PDF »
Inhibition of protein phosphatase 1 by inhibitor-2 gene delivery ameliorates heart failure progression in genetic cardiomyopathy.
M. Yamada, Y. Ikeda, M. Yano, K. Yoshimura, S. Nishino, H. Aoyama, L. Wang, H. Aoki, and M. Matsuzaki (2006)
FASEB J
20, 1197-1199
|Abstract »|Full Text »|PDF »
Is the Ryanodine Receptor a Target for Antiarrhythmic Therapy?.
C. Pott and J. I. Goldhaber (2006)
Circ. Res.
98, 1232-1233
|Full Text »|PDF »
Reducing Ryanodine Receptor Open Probability as a Means to Abolish Spontaneous Ca2+ Release and Increase Ca2+ Transient Amplitude in Adult Ventricular Myocytes.
Stabilization of cardiac ryanodine receptor prevents intracellular calcium leak and arrhythmias.
S. E. Lehnart, C. Terrenoire, S. Reiken, X. H. T. Wehrens, L.-S. Song, E. J. Tillman, S. Mancarella, J. Coromilas, W. J. Lederer, R. S. Kass, et al. (2006)
PNAS
103, 7906-7910
|Abstract »|Full Text »|PDF »
Analysis of calstabin2 (FKBP12.6)-ryanodine receptor interactions: Rescue of heart failure by calstabin2 in mice.
F. Huang, J. Shan, S. Reiken, X. H. T. Wehrens, and A. R. Marks (2006)
PNAS
103, 3456-3461
|Abstract »|Full Text »|PDF »
Ryanodine receptor/calcium release channel PKA phosphorylation: A critical mediator of heart failure progression.
X. H. T. Wehrens, S. E. Lehnart, S. Reiken, J. A. Vest, A. Wronska, and A. R. Marks (2006)
PNAS
103, 511-518
|Abstract »|Full Text »|PDF »
New Cardioprotective Agent K201 Is Natriuretic and Glomerular Filtration Rate Enhancing.
The Fire From Within: The Biggest Ca2+ Channel Erupts and Dribbles.
M. E. Anderson (2005)
Circ. Res.
97, 1213-1215
|Full Text »|PDF »
Nuclear Targeting of Akt Enhances Ventricular Function and Myocyte Contractility.
M. Rota, A. Boni, K. Urbanek, M. E. Padin-Iruegas, T. J. Kajstura, G. Fiore, H. Kubo, E. H. Sonnenblick, E. Musso, S. R. Houser, et al. (2005)
Circ. Res.
97, 1332-1341
|Abstract »|Full Text »|PDF »
Correction of Defective Interdomain Interaction Within Ryanodine Receptor by Antioxidant Is a New Therapeutic Strategy Against Heart Failure.
M. Yano, S. Okuda, T. Oda, T. Tokuhisa, H. Tateishi, M. Mochizuki, T. Noma, M. Doi, S. Kobayashi, T. Yamamoto, et al. (2005)
Circulation
112, 3633-3643
|Abstract »|Full Text »|PDF »
Reconstitution of local Ca2+ signaling between cardiac L-type Ca2+ channels and ryanodine receptors: insights into regulation by FKBP12.6.
S. A. Goonasekera, S. R. W. Chen, and R. T. Dirksen (2005)
Am J Physiol Cell Physiol
289, C1476-C1484
|Abstract »|Full Text »|PDF »
Intracellular Calcium Handling Dysfunction and Arrhythmogenesis: A New Challenge for the Electrophysiologist.
S. G. Priori and C. Napolitano (2005)
Circ. Res.
97, 1077-1079
|Full Text »|PDF »
Ryanodine receptor binding to FKBP12 is modulated by channel activation state.
J.-L. Jones, D. F. Reynolds, F. A. Lai, and L. M. Blayney (2005)
J. Cell Sci.
118, 4613-4619
|Abstract »|Full Text »|PDF »
Modulation of CaV1.2 Channels by Mg2+ Acting at an EF-hand Motif in the COOH-terminal Domain.
S. Brunet, T. Scheuer, R. Klevit, and W. A. Catterall (2005)
J. Gen. Physiol.
126, 311-323
|Abstract »|Full Text »|PDF »
K. Kontula, P. J. Laitinen, A. Lehtonen, L. Toivonen, M. Viitasalo, and H. Swan (2005)
Cardiovasc Res
67, 379-387
|Abstract »|Full Text »|PDF »
Estrogen Inhibits Cardiomyocyte Hypertrophy in Vitro: ANTAGONISM OF CALCINEURIN-RELATED HYPERTROPHY THROUGH INDUCTION OF MCIP1.
A. Pedram, M. Razandi, M. Aitkenhead, and E. R. Levin (2005)
J. Biol. Chem.
280, 26339-26348
|Abstract »|Full Text »|PDF »
Enhancing calstabin binding to ryanodine receptors improves cardiac and skeletal muscle function in heart failure.
X. H. T. Wehrens, S. E. Lehnart, S. Reiken, R. van der Nagel, R. Morales, J. Sun, Z. Cheng, S.-X. Deng, L. J. de Windt, D. W. Landry, et al. (2005)
PNAS
102, 9607-9612
|Abstract »|Full Text »|PDF »
Defective Ryanodine Receptor Interdomain Interactions May Contribute to Intracellular Ca2+ Leak: A Novel Therapeutic Target in Heart Failure.
S. E. Lehnart, X. H.T. Wehrens, and A. R. Marks (2005)
Circulation
111, 3342-3346
|Full Text »|PDF »
Defective Regulation of Interdomain Interactions Within the Ryanodine Receptor Plays a Key Role in the Pathogenesis of Heart Failure.
T. Oda, M. Yano, T. Yamamoto, T. Tokuhisa, S. Okuda, M. Doi, T. Ohkusa, Y. Ikeda, S. Kobayashi, N. Ikemoto, et al. (2005)
Circulation
111, 3400-3410
|Abstract »|Full Text »|PDF »
Intracellular Calcium Dynamics and Anisotropic Reentry in Isolated Canine Pulmonary Veins and Left Atrium.
C.-C. Chou, M. Nihei, S. Zhou, A. Tan, A. Kawase, E. S. Macias, M. C. Fishbein, S.-F. Lin, and P.-S. Chen (2005)
Circulation
111, 2889-2897
|Abstract »|Full Text »|PDF »
Can Novel Therapies for Arrhythmias Caused by Spontaneous Sarcoplasmic Reticulum Ca2+ Release be Developed Using Mouse Models?.
Defective Cardiac Ryanodine Receptor Regulation During Atrial Fibrillation.
J. A. Vest, X. H.T. Wehrens, S. R. Reiken, S. E. Lehnart, D. Dobrev, P. Chandra, P. Danilo, U. Ravens, M. R. Rosen, and A. R. Marks (2005)
Circulation
111, 2025-2032
|Abstract »|Full Text »|PDF »
Mutant cardiac ryanodine receptors and ventricular arrhythmias: is 'gain-of-function' obligatory?.
A. M. Gomez and S. Richard (2004)
Cardiovasc Res
64, 3-5
|Full Text »|PDF »
Functional heterogeneity of ryanodine receptor mutations associated with sudden cardiac death.
N. Lowri Thomas, C. H. George, and F. Anthony Lai (2004)
Cardiovasc Res
64, 52-60
|Abstract »|Full Text »|PDF »
Sudden Death in Familial Polymorphic Ventricular Tachycardia Associated With Calcium Release Channel (Ryanodine Receptor) Leak.
S. E. Lehnart, X. H.T. Wehrens, P. J. Laitinen, S. R. Reiken, S.-X. Deng, Z. Cheng, D. W. Landry, K. Kontula, H. Swan, and A. R. Marks (2004)
Circulation
109, 3208-3214
|Abstract »|Full Text »|PDF »